SBTXARS Pharmaceuticals Inc


$ 8.80 $ -0.10 (-1.12 %)    

Thursday, 23-May-2024 15:54:01 EDT
QQQ $ 454.82 $ -7.03 (-1.53 %)
DIA $ 398.57 $ -6.65 (-1.67 %)
SPY $ 530.36 $ -7.02 (-1.32 %)
TLT $ 91.26 $ -0.66 (-0.72 %)
GLD $ 225.37 $ -3.43 (-1.57 %)
$ 8.93
$ 8.90
$ 8.79 x 155
$ 8.81 x 100
$ 8.74 - $ 8.96
$ 2.55 - $ 11.27
230,490
na
na
$ 1.02
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Over $280 Million in Combined Cash and Securities and at least Three Years Operating Runway to Support Launch and Commercializa...

 silverback-therapeutics-announced-fdas-acceptance-of-ars-pharmaceuticals-nda-for-neffy-epinephrine-nasal-spray-for-the-treatment-of-allergic-reactions-type-i-including-anaphylaxis

Silverback Therapeutics, Inc. (Nasdaq: SBTX) ("Silverback") today announced that the U.S.

 this-technology-stock-surged-235-here-are-77-biggest-movers-from-friday

Gainers

 this-consumer-defensive-stock-is-trading-higher-by-around-49-here-are-46-stocks-moving-in-fridays-mid-day-session

Gainers Pagaya Technologies Ltd. (NASDAQ: PGY) shares gained 93% to $10.32. Pagaya Technologies is expected to announce its...

 daily-biotech-pulse-vistagens-anxiety-study-fails-silverback-to-merge-with-firm-developing-epipen-alternative-setback-for-liminals-lead-asset

Here's a roundup of top developments in the biotech space over the last 24 hours:

 why-guardforce-ai-is-trading-higher-by-36-heres-24-stocks-moving-premarket

Gainers

 silverback-therapeutics-and-ars-pharmaceuticals-announce-merger

Silverback Therapeutics, Inc. (NASDAQ:SBTX) ("Silverback") and ARS Pharmaceuticals, Inc. ("ARS") today announce...

 silverback-therapeutics-q1-eps-070-down-from-054-yoy

Silverback Therapeutics (NASDAQ:SBTX) reported quarterly losses of $(0.70) per share. This is a 29.63 percent decrease over los...

 stocks-that-hit-52-week-lows-on-wednesday

  On Wednesday, 807 companies reached new 52-week lows.

 stocks-that-hit-52-week-lows-on-friday

  On Friday, 1043 companies hit new 52-week lows.

 benzingas-top-ratings-upgrades-downgrades-for-april-4-2022

Upgrades

 goldman-sachs-downgrades-silverback-therapeutics-to-neutral-lowers-price-target-to-35

Goldman Sachs analyst Paul Choi downgrades Silverback Therapeutics (NASDAQ:SBTX) from Buy to Neutral and lowers the price ta...

 stocks-that-hit-52-week-lows-on-friday

  On Friday, 111 companies set new 52-week lows.

 benzingas-top-ratings-upgrades-downgrades-for-april-1-2022

Upgrades

 jonestrading-downgrades-silverback-therapeutics-to-hold

JonesTrading analyst Soumit Roy downgrades Silverback Therapeutics (NASDAQ:SBTX) from Buy to Hold.

 svb-leerink-downgrades-silverback-therapeutics-to-market-perform-lowers-price-target-to-18

SVB Leerink analyst Daina Graybosch downgrades Silverback Therapeutics (NASDAQ:SBTX) from Outperform to Market Perform and l...

 hc-wainwright--co-downgrades-silverback-therapeutics-to-neutral

HC Wainwright & Co. analyst Edward White downgrades Silverback Therapeutics (NASDAQ:SBTX) from Buy to Neutral.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION